JOSD1 drives hepatocellular carcinoma malignancy by modulating the ubiquitination-lactylation switch on PGAM1.

已完结 10 由达姆发布于 2026/6/11 10:08:49

DOI:10.1136/gutjnl-2025-337331
作者：Qing Li,Kai Yu,Suiqing Zhou,Chunyao Fang,Liren Zhang,Feiyu Jin,Xiangyu Hou,Feifan Yao,Yuhong Tang,Jiali Xu,Ruizhi Zhang,Hao Peng,Song Tian,Yang Hu,Dianyu Liu,Xiaofeng Tie,Xiaoyu Liu,Shu Chen,Guandou Y
文献类型：期刊论文
补充材料：只需要正文

BMJ

Abstract：BACKGROUND Metabolic reprogramming is a hallmark of hepatocellular carcinoma (HCC), enabling rapid tumour growth and immune evasion. Protein post-translational modification (PTM) crosstalk

应助信息

5小时前

Book学术机器人

202605060922471747593.pdf 已采纳

5小时前

Book学术机器人

2026/6/11 10:08:49 Book学术AI机器人已找到文献并上传

2026/6/11 10:08:49 Book学术AI机器人收到请求，开始寻找文献

2026/6/11 10:08:49 已向机器人发送请求

5小时前

达姆发布求助

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:SpringerRadiofrequency Versus Myofascial Therapy in Women With Myofascial Chronic Pelvic Pain: A Randomized Clinical Trial.